Instron and Stelex Announce Partnership
This will ensure Compliance for testing equipment in the Life Science Industries
Canton, MA and Bensalem, PA, May 11, 2004 – Instron®,a leading provider of testing equipment designed to evaluate mechanical properties of materials and components, and Stelex, a firm providing enterprise-wide compliance solutions to the regulated industries, today announced an alliance to provide cost-effective solutions for life science companies to achieve compliance with Electronic Record/Electronic Signature (ERES) requirements. Through this partnership and the implementation of Stelex’ ComplianceBuilder™, the two companies will offer enterprise-wide data visibility and monitoring capabilities.
According to Richard McManuis, Product Manager for Instron, “Our partnership with Stelex allows us to offer our customers an affordable, add-on compliance solution that provides capabilities to comply with 21CFR Part 11 requirements by providing time-stamped audit trails, system security, comprehensive reporting and accurate data storage. Also, because ComplianceBuilder™ works with Instron’s proprietary software, including Merlin™, Series IX™ and Bluehill™, the revalidation requirements for these systems are significantly reduced, resulting in increased time and resource savings.”
“We are very excited about our alliance with Instron,” said Daniel R. Matlis, Vice-President and General Manager of Partnerships at Stelex. “The regulatory landscape has been redesigned through the use of risk-based approaches to achieve compliance. Life Science companies are looking for both common sense and cost effective approaches to compliance. The integration of Instron’s proprietary software and Stelex’ ComplianceBuilder™, will provide a cost effective solution for this critical issue facing the industry.”
About Instron
Instron® is a leading provider of testing equipment for the material testing, and structural testing markets. Instron’s products test the mechanical properties and performance of various materials, components and structures in a wide array of environments. A global company providing single-source convenience, Instron is a full-service materials testing company that manufactures and services testing instruments, systems, software and accessories. Instron’s proficiency in designing and building testing systems to evaluate materials ranging from the most fragile filament to advanced alloys, affords Instron’s customers a comprehensive resource for all their research, quality and service-life testing requirements.
For more information, contact Instron, 100 Royall Street, Canton, MA 02021; 800-695-4273; fax 781-575-5770; email info_news@instron.com. Information is also available on the company’s enhanced website at www.instron.com/pr.
About Stelex
Stelex is a consulting firm providing enterprise-wide compliance solutions to regulated industries in the Pharmaceutical, Medical Device, Diagnostic and Biotechnology sectors for over 20 years. The firm delivers a comprehensive suite of Validation, Technology, Regulatory and Business solutions. Learn more about Stelex at www.stelex.com.
Stelex is a subsidiary of
Vital Signs, Inc. (NASDAQ: VITL).
Vital Signs Inc. provide products and services to the hospital market and FDA regulated industries. Vital Signs is ISO 9001 certified and has CE Mark approval for its products.
Release Statement
All statements in this press release other than historical statements constitute Forward Looking Statements under the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from such statements as a result of a variety of factors, including but not limited to the changes in regulatory requirements in the United States and elsewhere, timing and effectiveness of changes to marketing and sales plans, programs and strategies; market conditions; customer response; technological change; and competition and other factors referred to by Vital Signs in its Annual Report on Form 10-K for the year ended September 30, 2003 and other reports filed with the Securities and Exchange Commission.